» Articles » PMID: 30295477

Nitro-Group-Containing Drugs

Overview
Journal J Med Chem
Specialty Chemistry
Date 2018 Oct 9
PMID 30295477
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

The nitro group is considered to be a versatile and unique functional group in medicinal chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues and is often categorized as a structural alert or a toxicophore, and evidence related to drugs containing nitro groups is rather contradictory. In general, drugs containing nitro groups have been extensively associated with mutagenicity and genotoxicity. In this context, efforts toward the structure-mutagenicity or structure-genotoxicity relationships have been undertaken. The current Perspective covers various aspects of agents that contain nitro groups, their bioreductive activation mechanisms, their toxicities, and approaches to combat their toxicity issues. In addition, recent advances in the field of anticancer, antitubercular and antiparasitic agents containing nitro groups, along with a patent survey on hypoxia-activated prodrugs containing nitro groups, are also covered.

Citing Articles

Ni(ii)/spiroBox-catalyzed asymmetric Friedel-Crafts alkylation of indoles with nitroalkenes.

Li Y, Sun S, Jiao L, Gao N, Cao G RSC Adv. 2025; 15(10):7644-7648.

PMID: 40065808 PMC: 11891994. DOI: 10.1039/d4ra08471c.


Synthesis and in vitro antitrypanosomatid activity of novel 5-nitroindole-rhodanine conjugates.

Badenhorst E, Aucamp J, Kannigadu C, Janse van Rensburg H, Suganuma K, NDa D Future Med Chem. 2025; 17(5):557-573.

PMID: 39995114 PMC: 11901381. DOI: 10.1080/17568919.2025.2470110.


New tetrahydroisoquinolines bearing nitrophenyl group targeting HSP90 and RET enzymes: synthesis, characterization and biological evaluation.

Bakhite E, Hassanien R, Farhan N, Sayed E, Sharaky M BMC Chem. 2025; 19(1):46.

PMID: 39985107 PMC: 11846289. DOI: 10.1186/s13065-025-01399-0.


A review on pyrimidine-based pharmacophore as a template for the development of hybrid drugs with anticancer potential.

Sharma S, Babu M, Kumar R, Singh T, Dwivedi A, Ahmad G Mol Divers. 2025; .

PMID: 39937329 DOI: 10.1007/s11030-025-11112-x.


Development of a novelly selective HPLC-chemiluminescence method by targeting degradation intermediates of nitroimidazoles and its application in animal food products.

Cai M, Wang X, Lu K, Zhou B, Wei L, Cheng X Food Chem X. 2025; 25:102205.

PMID: 39925759 PMC: 11803852. DOI: 10.1016/j.fochx.2025.102205.